Loading insider details...
Beta
Latest Form 4 (Nov 19, 2025): Grant/Award of 84,411 MRKR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 19, 2025 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 84,411 | n/a |
| Feb 14, 2025 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 30,000 | n/a |
| Jun 9, 2023 | Marker Therapeutics, Inc. (MRKR) | Purchase | 14,285 | $250.0K |
| May 26, 2022 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 80,000 | n/a |
| Nov 16, 2021 | BIO-TECHNE Corp (TECH) | Exercise/Conversion | 27,159 | $3.40M |
| Sep 2, 2021 | BIO-TECHNE Corp (TECH) | Sale | 1,538 | $773.7K |
| Aug 10, 2021 | BIO-TECHNE Corp (TECH) | Exercise/Conversion | 2,537 | n/a |
| Jun 10, 2021 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 12,658 | n/a |
| Feb 9, 2021 | BIO-TECHNE Corp (TECH) | Exercise/Conversion | 14,114 | $1.50M |
| Aug 11, 2020 | BIO-TECHNE Corp (TECH) | Exercise/Conversion | 2,174 | n/a |